Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Radiother Oncol. 2009 Jun 22;93(1):32–36. doi: 10.1016/j.radonc.2009.05.018

Table 3.

Comparison of dose–volume characteristics and plan parameters between functionally and anatomically optimised plans.

Scenario V 20
FV 20
MLD
MFLD
V PTV95
VPTV95:FV20
A F A F A F A F A F A F
1 25.2 23.8 14.7 13.4 13.8 13.8 9.7 9.8 92.9 93.1 6.3 7.0
2 29.8 28.9 21.1 20.1 16.1 16.0 12.4 12.2 93.2 93.2 4.4 4.4
3 24.5 24.0 11.1 8.1 14.0 14.0 9.9 9.2 91.0 91.0 8.2 11.2
4 30.4 29.5 17.3 16.8 15.8 15.4 11.0 10.7 91.1 91.0 5.3 5.4
5 24.5 22.4 14.6 11.9 13.7 13.3 9.9 9.4 90.4 90.3 6.2 7.6
6 25.6 24.1 7.2 3.7 13.7 13.7 8.2 7.6 91.8 91.4 12.8 24.6
7 20.9 18.2 10.1 6.6 10.8 10.6 7.1 6.7 90.4 91.4 8.9 13.8
Median 25.2 24.0 14.6 11.8 13.8 13.8 9.9 9.4 91.8 91.4 6.3 7.6
p Value 0.02 0.02 0.07 0.03 1.00 0.02

Data are presented for the most favourable plan generated using anatomical data (A), and with combined anatomical and functional data (F). Abbreviations: V2, percent volume of lung receiving ≥20 Gy; FV20, percent volume of functional lung receiving ≥20 Gy; MLD, mean lung dose in Gy; MFLD, mean functional lung dose in Gy; VPTV95, percent volume of planning target volume (PTV) covered by the 95% isodose; VPTV95:FV20, plan quality index consisting of the ratio of VPTV95 to FV20.